October 4, 2014

Poster - 2014 American College of Clinical Pharmacy Annual Meeting


My poster for the 2014 American College of Clinical Pharmacy Annual Meeting

My abstract for the 2014 American College of Clinical Pharmacy Annual Meeting

Systematic Literature Review of Randomized Controlled Trials to Evaluate the Efficacy of Medical Marijuana for Analgesia
Shiny Parsai, M.S., Pharm.D. Candidate, Ronald A. Herman, Ph.D.; The University of Iowa College of Pharmacy, Sarah J. Johnson, Pharm.D., BCPS-AQ ID; The University of Iowa Healthcare

Purpose: Medical marijuana has had an evolving and controversial role for the treatment of pain.  This review summarizes and evaluates the current evidence from randomized controlled trials to examine the efficacy of medical marijuana as an analgesic. Methods: A systematic literature review was conducted using PubMed, IDIS, IPA, and CINAHL databases.  Articles were included if analgesia was a measured outcome in humans, the intervention involved tetrahydrocannabinol (THC) or derivative, was a randomized controlled trial, and was in English. Two authors did an initial screen of the abstracts to eliminate irrelevant articles and then a detailed review of the full text to identify the articles to be included in the evidence tables.  The third author reconciled differences if there was not a consensus. Data extraction included author name, date, type of pain, sample size, study design, intervention, efficacy, and adverse effects.  Evidence was organized and analyzed in separate evidence tables by type of intervention: inhaled cannabis, oral cannabis extracts, dronabinol, THC+CBD spray, and synthetic analogs. Results:  The initial literature search produced 133 unique articles.  Systematic review of abstracts, yielded 66 for full text review and 67 were excluded.   Full text review resulted in 48 articles to be included in the evidence tables. Conclusions:  Across each intervention type at least half of the studies showed a reduction in pain scores when compared to placebo.  There were 11 of 48 studies that indicated no difference from placebo for analgesia, with at least one study in each intervention type. There were 6 studies that compared the THC compound to another analgesic. It was not different from ibuprofen in one study, diphenhydramine in another study, and it was equivalent to codeine in two studies.  It was inferior to dihydrocodeine and to morphine in separate studies.  Adverse events were a concern in some of the studies.